The Progression of a Transcatheter Aortic Valve Program: A Decision Analysis of More Than 680 Patient Referrals Joseph E. Bavaria, MD, Wilson Y. Szeto, MD, Lauren A. Roche, BS, Elizabeth K. Walsh, RN, Virginia Buckley-Blaskovich, CRNP, Lauren P. Solometo, BS, Kristen E. Burtch, BS, Nimesh D. Desai, MD, PhD, Howard C. Herrmann, MD The Annals of Thoracic Surgery Volume 92, Issue 6, Pages 2072-2077 (December 2011) DOI: 10.1016/j.athoracsur.2011.06.060 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Referrals for transcatheter aortic valve repair (TAVR) trial: trial enrollments, failures, and other categories. (AVA = aortic valve area; CAD = coronary artery disease; EF = ejection fraction.) The Annals of Thoracic Surgery 2011 92, 2072-2077DOI: (10.1016/j.athoracsur.2011.06.060) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Clinical disposition of all patients who failed TAVR trial enrollment. (AVR = aortic valve replacement; BAV = balloon aortic valvuloplasty.) The Annals of Thoracic Surgery 2011 92, 2072-2077DOI: (10.1016/j.athoracsur.2011.06.060) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions